Dianne L Carey

Summary

Affiliation: University of New South Wales
Country: Australia

Publications

  1. ncbi request reprint Once-daily therapies
    Dianne Carey
    National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, Level 2, 376 Victoria Street, Darlinghurst NSW 2010, Australia
    J HIV Ther 8:7-11. 2003
  2. ncbi request reprint A randomized, multicenter, open-label study of poly-L-lactic acid for HIV-1 facial lipoatrophy
    Dianne L Carey
    National Centre in HIV Epidemiology and Clinical Research, The University of New South Wales, Sydney, Australia
    J Acquir Immune Defic Syndr 46:581-9. 2007
  3. ncbi request reprint Restorative interventions for HIV facial lipoatrophy
    Dianne Carey
    National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, Sydney, Australia
    AIDS Rev 10:116-24. 2008
  4. doi request reprint Lipid profiles in HIV-infected adults receiving atazanavir and atazanavir/ritonavir: systematic review and meta-analysis of randomized controlled trials
    Dianne Carey
    National Centre in HIV Epidemiology and Clinical Research, The University of New South Wales, Sydney 2052, New South Wales, Australia
    J Antimicrob Chemother 65:1878-88. 2010
  5. ncbi request reprint Metabolic syndrome, cardiovascular disease and type 2 diabetes mellitus after initiation of antiretroviral therapy in HIV infection
    Handan Wand
    National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, Australia
    AIDS 21:2445-53. 2007

Detail Information

Publications5

  1. ncbi request reprint Once-daily therapies
    Dianne Carey
    National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, Level 2, 376 Victoria Street, Darlinghurst NSW 2010, Australia
    J HIV Ther 8:7-11. 2003
    ..It is possible that in the future, once-daily dosing will become the standard...
  2. ncbi request reprint A randomized, multicenter, open-label study of poly-L-lactic acid for HIV-1 facial lipoatrophy
    Dianne L Carey
    National Centre in HIV Epidemiology and Clinical Research, The University of New South Wales, Sydney, Australia
    J Acquir Immune Defic Syndr 46:581-9. 2007
    ..Facial lipoatrophy can stigmatize and can reduce quality of life, self esteem, and antiretroviral adherence. Poly-L-lactic acid (PLA) injections seem safe and effective, but no randomized study has included objective endpoints...
  3. ncbi request reprint Restorative interventions for HIV facial lipoatrophy
    Dianne Carey
    National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, Sydney, Australia
    AIDS Rev 10:116-24. 2008
    ..However, well-designed studies with objectively assessed endpoints are needed to elucidate optimal treatments for this distressing condition...
  4. doi request reprint Lipid profiles in HIV-infected adults receiving atazanavir and atazanavir/ritonavir: systematic review and meta-analysis of randomized controlled trials
    Dianne Carey
    National Centre in HIV Epidemiology and Clinical Research, The University of New South Wales, Sydney 2052, New South Wales, Australia
    J Antimicrob Chemother 65:1878-88. 2010
    ..To compare lipid profiles in HIV-infected adults receiving atazanavir-based regimens...
  5. ncbi request reprint Metabolic syndrome, cardiovascular disease and type 2 diabetes mellitus after initiation of antiretroviral therapy in HIV infection
    Handan Wand
    National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, Australia
    AIDS 21:2445-53. 2007
    ..Metabolic syndrome (MS) identifies individuals at risk of cardiovascular disease (CVD) and type 2 diabetes mellitus (T2DM). Little is known about MS and its consequences following initiation of antiretroviral therapy (ART)...